drugset / Trial / NCT06867406
A Trial to Evaluate KPC000154 Tablets in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KPC000154 Tablets in Healthy Subjects
Timeline
- Start
- 2025-03-07
- Primary completion
- 2025-11-30
- Completion
- 2026-01-31
Publications
- Results https://cmab.yiigle.com/uploads/guide_html/%E9%9D%9E%E9%85%92%E7%B2%BE%E6%80%A7%E8%84%82%E8%82%AA%E6%80%A7%E8%82%9D%E7%97%85%E9%98%B2%E6%B2%BB%E6%8C%87%E5%8D%97(2018%E6%9B%B4%E6%96%B0%E7%89%88).html
- Results Osaki Y, Takasawa M, Doi K, Nishimura H, Iwaki T, Imaizumi M, Oku N, Hatazawa J, Kubo T. Auditory and tactile processing in a postmeningitic deaf-blind patient with a cochlear implant. Neurology. 2006 Sep 12;67(5):887-90. doi: 10.1212/01.wnl.0000234141.72891.13.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KPC000154 | Unknown | 10 mg | Oral |
| Subject | KPC000154 | Unknown | 30 mg | Oral |
| Subject | KPC000154 | Unknown | 40 mg | Oral |
| Subject | KPC000154 | Unknown | 60 mg | Oral |
| Subject | KPC000154 | Unknown | 80 mg | Oral |
| Subject | KPC000154 | Unknown | 120 mg | Oral |
| Subject | KPC000154 | Unknown | 200 mg | Oral |
| Subject | KPC000154 | Unknown | 300 mg | Oral |
| Subject | KPC000154 | Unknown | 400 mg | Oral |